1.24BMarket Cap
LossP/E TTM
Immatics NV's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Immatics NV is 7.44, ranking 236 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -12.01, which is -544.39% below the recent high of 53.38 and -261.26% above the recent low of -43.40.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.